OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Intratumoral bacteria are an important “accomplice” in tumor development and metastasis
Gang Wang, Xianli He, Qian Wang
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2022) Vol. 1878, Iss. 1, pp. 188846-188846
Closed Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Intratumoural microbiome can predict the prognosis of hepatocellular carcinoma after surgery
Lejia Sun, Xindi Ke, Ai Guan, et al.
Clinical and Translational Medicine (2023) Vol. 13, Iss. 7
Open Access | Times Cited: 40

Intratumoral microbiota: implications for cancer onset, progression, and therapy
Jinmei Wu, Pengfei Zhang, Wuxuan Mei, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 14

Microbiome and lung cancer: carcinogenic mechanisms, early cancer diagnosis, and promising microbial therapies
Weici Liu, Zheshun Pi, Xiaokun Wang, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 196, pp. 104322-104322
Closed Access | Times Cited: 7

Akkermansia muciniphila-derived pentadecanoic acid enhances oxaliplatin sensitivity in gastric cancer by modulating glycolysis
Qixuan Xu, Jingwang Gao, Ruiyang Zhao, et al.
Pharmacological Research (2024) Vol. 206, pp. 107278-107278
Open Access | Times Cited: 7

Unveiling the intratumoral microbiota within cancer landscapes
Shusheng Che, Zhiyong Yan, Yugong Feng, et al.
iScience (2024) Vol. 27, Iss. 6, pp. 109893-109893
Open Access | Times Cited: 6

How Can the Microbiome Induce Carcinogenesis and Modulate Drug Resistance in Cancer Therapy?
Inês Mendes, Nuno Vale
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11855-11855
Open Access | Times Cited: 15

Intratumoral Microbiota as a Target for Advanced Cancer Therapeutics
Fei Peng, Mengyuan Hu, Zhiyue Su, et al.
Advanced Materials (2024) Vol. 36, Iss. 38
Closed Access | Times Cited: 5

Unveiling the Intratumor Microbiome in Liver Cancer: Current Insights and Prospective Applications
Xindi Ke, Shangze Jiang, Qiaoxin Wei, et al.
Clinical and Molecular Hepatology (2025)
Open Access

Multiomics insights into BMI-related intratumoral microbiota in gastric cancer
Kang Liu, Zhengchen Jiang, Yubo Ma, et al.
Frontiers in Cellular and Infection Microbiology (2025) Vol. 15
Open Access

Targeting gut microbiota: a potential therapeutic approach for tumor microenvironment in glioma
Q H Fan, Kaiqiang Meng, Xiaoping Zhao, et al.
Frontiers in Neurology (2025) Vol. 16
Open Access

Research progress on fecal microbiota transplantation in tumor prevention and treatment
Yajun Wu, Zike Lei, Qingming Wu, et al.
Open Life Sciences (2025) Vol. 20, Iss. 1
Open Access

The crosstalk of intratumor bacteria and the tumor
Jiating Huang, Yuqin Mao, Li‐Shun Wang
Frontiers in Cellular and Infection Microbiology (2024) Vol. 13
Open Access | Times Cited: 4

Harnessing and Mimicking Bacterial Features to Combat Cancer: From Living Entities to Artificial Mimicking Systems
Peng Gao, Zhenyu Duan, Gang Xu, et al.
Advanced Materials (2024) Vol. 36, Iss. 35
Closed Access | Times Cited: 2

Elucidating the Intricate Roles of Gut and Breast Microbiomes in Breast Cancer Metastasis to the Bone
Amruta P. Barhanpurkar, Mukul Godbole
Cancer Reports (2024) Vol. 7, Iss. 8
Open Access | Times Cited: 2

Leucine restriction ameliorates Fusobacterium nucleatum-driven malignant progression and radioresistance in nasopharyngeal carcinoma
Songhe Guo, Shan Xing, Zhenyu Wu, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 10, pp. 101753-101753
Open Access | Times Cited: 2

Progress of tumor-resident intracellular bacteria for cancer therapy
Peng Bao, Xian‐Zheng Zhang
Advanced Drug Delivery Reviews (2024) Vol. 214, pp. 115458-115458
Closed Access | Times Cited: 2

Role of the intratumoral microbiome in tumor progression and therapeutics implications
Yufan Meng, Zhiyao Fan, Bin Zhou, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 6, pp. 189014-189014
Closed Access | Times Cited: 6

Deciphering the Puzzle: Literature Insights on Chlamydia trachomatis-Mediated Tumorigenesis, Paving the Way for Future Research
Rafaela Rodrigues, Carlos Sousa, Nuno Vale
Microorganisms (2024) Vol. 12, Iss. 6, pp. 1126-1126
Open Access | Times Cited: 1

Identification of Breast Cancer LCK Proto-Oncogene as a Master Regulator of TNBC Neutrophil Enrichment and Polarization
Fatma Al Qutami, Walaa Al Halabi, Mahmood Yaseen Hachim
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13269-13269
Open Access | Times Cited: 3

Bacteria associated with glioma: a next wave in cancer treatment
Yiming Meng, Jing Sun, Guirong Zhang, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 2

Realising the therapeutic potential of the human microbiota in metastatic pancreatic ductal adenocarcinoma
James Halle‐Smith, Lewis Hall, Sarah Powell‐Brett, et al.
Clinical Surgical Oncology (2023) Vol. 2, Iss. 4, pp. 100020-100020
Open Access | Times Cited: 2

The intratumoral microbiota: a new horizon in cancer immunology
Wei Liu, Yuming Li, Ping Wu, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access

Page 1 - Next Page

Scroll to top